CONTEXT: There have been very few randomized controlled treatment studies of anorexia nervosa. OBJECTIVE: To evaluate factors leading to nonacceptance and noncompletion of treatment for 2 specific therapies and their combination in the treatment of anorexia nervosa. DESIGN: Randomized prospective study. SETTING: Weill-Cornell Medical Center, White Plains, NY; University of Minnesota, Minneapolis; and Stanford University, Stanford, Calif. PatientsOne hundred twenty-two patients meeting DSM-IV criteria for anorexia nervosa. INTERVENTIONS: Treatment with cognitive-behavioral therapy, fluoxetine hydrochloride, or their combination for 1 year. MAIN OUTCOME MEASURES: Dropout rate and acceptance of treatment (defined as staying in treatment at least 5 weeks). RESULTS: Of the 122 randomized cases, 21 (17%) were withdrawn; the overall dropout rate was 46% (56/122) in the remaining patients. Treatment acceptance occurred in 89 (73%) of the 122 randomized cases. Of the 41 assigned to medication alone, acceptance occurred in 23 (56%). In the other 2 groups, acceptance rate was differentiated by high and low obsessive preoccupation scores (rates of 91% and 60%, respectively). The only predictor of treatment completion was high self-esteem, which was associated with a 51% rate of treatment acceptance. CONCLUSION:Acceptance of treatment and relatively high dropout rates pose a major problem for research in the treatment of anorexia nervosa. Differing characteristics predict dropout rates and acceptance, which need to be carefully studied before comparative treatment trials are conducted.
RCT Entities:
CONTEXT: There have been very few randomized controlled treatment studies of anorexia nervosa. OBJECTIVE: To evaluate factors leading to nonacceptance and noncompletion of treatment for 2 specific therapies and their combination in the treatment of anorexia nervosa. DESIGN: Randomized prospective study. SETTING: Weill-Cornell Medical Center, White Plains, NY; University of Minnesota, Minneapolis; and Stanford University, Stanford, Calif. Patients One hundred twenty-two patients meeting DSM-IV criteria for anorexia nervosa. INTERVENTIONS: Treatment with cognitive-behavioral therapy, fluoxetine hydrochloride, or their combination for 1 year. MAIN OUTCOME MEASURES: Dropout rate and acceptance of treatment (defined as staying in treatment at least 5 weeks). RESULTS: Of the 122 randomized cases, 21 (17%) were withdrawn; the overall dropout rate was 46% (56/122) in the remaining patients. Treatment acceptance occurred in 89 (73%) of the 122 randomized cases. Of the 41 assigned to medication alone, acceptance occurred in 23 (56%). In the other 2 groups, acceptance rate was differentiated by high and low obsessive preoccupation scores (rates of 91% and 60%, respectively). The only predictor of treatment completion was high self-esteem, which was associated with a 51% rate of treatment acceptance. CONCLUSION: Acceptance of treatment and relatively high dropout rates pose a major problem for research in the treatment of anorexia nervosa. Differing characteristics predict dropout rates and acceptance, which need to be carefully studied before comparative treatment trials are conducted.
Authors: Lisa Brownstone; Kristen Anderson; Judy Beenhakker; James Lock; Daniel Le Grange Journal: Int J Eat Disord Date: 2012-03-12 Impact factor: 4.861
Authors: Madhusmita Misra; Debra K Katzman; Nara Mendes Estella; Kamryn T Eddy; Thomas Weigel; Mark A Goldstein; Karen K Miller; Anne Klibanski Journal: J Clin Psychiatry Date: 2013-08 Impact factor: 4.384
Authors: Dara L Bellace; Rebecca Tesser; Samantha Berthod; Kimberly Wisotzke; Ross D Crosby; Scott J Crow; Scott G Engel; Daniel Le Grange; James E Mitchell; Carol B Peterson; Heather K Simonich; Stephen A Wonderlich; Katherine A Halmi Journal: Int J Eat Disord Date: 2012-04-25 Impact factor: 4.861
Authors: Alison M Darcy; Susan W Bryson; W Stewart Agras; Kathleen Kara Fitzpatrick; Daniel Le Grange; James Lock Journal: Behav Res Ther Date: 2013-09-15
Authors: Christina E Wierenga; Amanda Bischoff-Grethe; A James Melrose; Zoe Irvine; Laura Torres; Ursula F Bailer; Alan Simmons; Julie L Fudge; Samuel M McClure; Alice Ely; Walter H Kaye Journal: Biol Psychiatry Date: 2014-10-22 Impact factor: 13.382